InsidersTradesSigma
Explore the detailed record of transactions filed by Hively Brad, Chief Executive Officer. Insider active across 1 company, notably Oncology Institute, Inc.. Cumulatively, 5 reports have been logged. History available since 12 January 2021. The latest transaction was disclosed on 21 March 2022 (Attribution). Regulator: SEC (Form 4). All data is openly available.
5 of 5 declarations
Brad Hively is the Chief Executive Officer of Oncology Institute, Inc. He leads the company with a focus on innovation and improving patient care. His leadership is essential for the mission and objectives of Oncology Institute.